- Home
- VNDA vs BWAY Comparison
VNDA vs BWAY Comparison
Compare VNDA & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- BWAY
- Stock Information
- Founded
- VNDA 2002
- BWAY 2003
- Country
- VNDA United States
- BWAY Israel
- Employees
- VNDA N/A
- BWAY N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- BWAY Medical/Dental Instruments
- Sector
- VNDA Health Care
- BWAY Health Care
- Exchange
- VNDA Nasdaq
- BWAY Nasdaq
- Market Cap
- VNDA 249.4M
- BWAY 280.7M
- IPO Year
- VNDA 2006
- BWAY 2019
- Fundamental
- Price
- VNDA $4.39
- BWAY $16.06
- Analyst Decision
- VNDA Strong Buy
- BWAY Strong Buy
- Analyst Count
- VNDA 2
- BWAY 2
- Target Price
- VNDA $16.50
- BWAY $18.00
- AVG Volume (30 Days)
- VNDA 346.2K
- BWAY 77.7K
- Earning Date
- VNDA 11-05-2025
- BWAY 11-11-2025
- Dividend Yield
- VNDA N/A
- BWAY N/A
- EPS Growth
- VNDA N/A
- BWAY 515.14
- EPS
- VNDA N/A
- BWAY 0.11
- Revenue
- VNDA $203,467,000.00
- BWAY $46,084,000.00
- Revenue This Year
- VNDA $15.45
- BWAY $339.49
- Revenue Next Year
- VNDA $37.82
- BWAY $21.74
- P/E Ratio
- VNDA N/A
- BWAY $58.19
- Revenue Growth
- VNDA 11.78
- BWAY 26.50
- 52 Week Low
- VNDA $3.81
- BWAY $7.84
- 52 Week High
- VNDA $5.55
- BWAY $17.00
- Technical
- Relative Strength Index (RSI)
- VNDA 42.54
- BWAY 60.10
- Support Level
- VNDA $4.36
- BWAY $15.01
- Resistance Level
- VNDA $4.64
- BWAY $17.00
- Average True Range (ATR)
- VNDA 0.16
- BWAY 0.66
- MACD
- VNDA -0.03
- BWAY -0.07
- Stochastic Oscillator
- VNDA 5.36
- BWAY 60.50
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.